Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
VALEANT PHARMACEUTICALS INTL INC
T.VRX
Healthcare
Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:VRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
johnnywick
X
View Profile
View Bullboard History
Post by
johnnywick
on Aug 02, 2017 6:14pm
go to youtube and watch videos showing people with psoriasis
from watching all the videos.. i say if you have psoriasis,,, u will try any new drugs to fight the diseases. valeant's siliq going to do well in this market.. if you're a patient suffering
...more
(0)
•••
johnnywick
X
View Profile
View Bullboard History
Comment by
johnnywick
on Aug 02, 2017 6:09pm
RE:Valeant Pharma (VRX) Reports Launch of SILIQ (brodalumab)
very bullish people that have long term psoriasis will try any new drugs .. this bold wells for siliq Valeant is a winner
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(0)
•••
johnnywick
X
View Profile
View Bullboard History
Comment by
johnnywick
on Aug 02, 2017 5:15pm
RE:Shorts are all trapped.. approx 16 million shares shorted
lots of shorts to cook this month.. August 2017
(0)
•••
johnnywick
X
View Profile
View Bullboard History
Comment by
johnnywick
on Aug 02, 2017 5:11pm
RE:PDUFA .. AUGUST 24, 2017 ( BIG BIG NEWS THIS MONTH )
only 3 weeks away .. PDUFA / AUGUST 24 Is the market going to run up VRX ahead of this BIG BIG NEWS ?? ?? most likely going to get approved
(0)
•••
johnnywick
X
View Profile
View Bullboard History
Post by
johnnywick
on Aug 02, 2017 5:06pm
PDUFA .. AUGUST 24, 2017 ( BIG BIG NEWS THIS MONTH )
Bausch + Lomb And Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod PDUFA .. AUGUST 24, 2017
(0)
•••
johnnywick
X
View Profile
View Bullboard History
Post by
johnnywick
on Aug 02, 2017 4:40pm
Vyzulta
Vyzulta market opportunity According to Valeant’s estimates, approximately 3 million people in the United States have glaucoma. The company has valued the total US glaucoma market opportunity at
...more
(0)
•••
johnnywick
X
View Profile
View Bullboard History
Post by
johnnywick
on Aug 02, 2017 4:07pm
Wells Fargo .. finally chickened out
Wells Fargo already made a fool of themselves so many times by bashing valeant .. now finally chickened out and wave the white flag.. who's next ? Just look at all the insiders buying in valeant
...more
(0)
•••
johnnywick
X
View Profile
View Bullboard History
Post by
johnnywick
on Aug 02, 2017 4:01pm
heavy insiders buying is very [ positive ] for VRX
Stifel Nicolaus reiterated a buy rating and issued a $35.00 price target on shares of Valeant Pharmaceuticals
(20)
•••
domcolumba
X
View Profile
View Bullboard History
Post by
domcolumba
on Aug 02, 2017 3:16pm
More Trouble for Wells Fargo
https://www.cnbc.com/2017/08/02/lawsuit-says-wells-fargo-auto-insurance-charges-were-a-fraud.html Maybe another reason they dropped coverage of Valeant. The crooks have other business to attend to
...more
(20)
•••
domcolumba
X
View Profile
View Bullboard History
Comment by
domcolumba
on Aug 01, 2017 10:47am
RE:Wells Fargo & Company Drops Coverage on Valeant
Wells Fargo & Company Drops Coverage on Valeant Pharmaceuticals International, Inc. (VRX) Posted by Wayne Landers on Jul 31st, 2017 // No Comments Wells Fargo & Company dropped coverage on
...more
(5)
•••
Abruzzo
X
View Profile
View Bullboard History
Post by
Abruzzo
on Aug 01, 2017 6:50am
Wells Fargo & Company Drops Coverage on Valeant
What about David Maris's $8 target price for VRX? I'm going to miss the entertainment value of his analysis.
(2)
•••
mtgfree1
X
View Profile
View Bullboard History
Post by
mtgfree1
on Jul 31, 2017 10:26am
Buy Vrx
$20.47 filled
(0)
•••
FerrariPalmbeac
X
View Profile
View Bullboard History
Post by
FerrariPalmbeac
on Jul 31, 2017 9:56am
14 MINUTES AGO
14 minutes ago: https://www.benchmarkmonitor.com/2-analysts-given-buy-rating-valeant-pharmaceuticals-intl-inc-nysevrx/237742
(0)
•••
Ichimek
X
View Profile
View Bullboard History
Post by
Ichimek
on Jul 28, 2017 4:31pm
New good spot for SL
For ones investing for short term gains, we have new SL spot. info here
(4)
•••
Catmando123
X
View Profile
View Bullboard History
Post by
Catmando123
on Jul 27, 2017 9:39am
Valeant Pharma (VRX) Reports Launch of SILIQ (brodalumab)
https://www.streetinsider.com/Corporate+News/Valeant+Pharma+%28VRX%29+Reports+Launch+of+SILIQ+%28brodalumab%29+Injection/13135660.html
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >